MILAN ( – In the first quarter, Kolinpharma medical prescriptions have increased by 46% compared to the same period in 2017. “We are extremely satisfied with the results concerning the medical prescriptions of the first three months in 2018 showing a positive trend and confirming the potential for growth in the market – said Emanuele Lusenti, CEO of Kolinpharma – With the creation of a foreign division, we aim to strengthen our development beyond national borders to those countries where the opportunities in the nutraceutical market can best be exploited”. In fact, four new medical and scientific specialists were included in the group’s commercial area, while a new resource will undertake the role of International Assistance manager.